INmune Bio, Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US45782T1051
USD
1.42
-0.13 (-8.39%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryINmune Bio, Inc. VS Pharmaceuticals & Biotechnology
 
1D
-8.39%
-0.51%
1W
-11.8%
-1.37%
1M
-7.79%
0.35%
YTD
-8.97%
0.54%
1Y
-84.75%
13.99%
3Y
-83.49%
66.39%
5Y
-93.63%
77.77%
10Y
-93.63%
259.33%
  • Stock Absolute Returns
  • S&P 500Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-17.44%
0%
-17.44%
6 Months
-50.26%
0%
-50.26%
1 Year
-84.75%
0%
-84.75%
2 Years
-87.18%
0%
-87.18%
3 Years
-83.49%
0%
-83.49%
4 Years
-86.29%
0%
-86.29%
5 Years
-93.63%
0%
-93.63%

INmune Bio, Inc. for the last several years.

stock-summaryRisk Adjusted Returns v/s S&P 500
Risk Adjusted Returns v/s stock-summary